Treatment satisfaction with different weight loss methods among respondents with obesity

被引:9
|
作者
Gupta, S. [1 ]
Wang, Z. [2 ]
机构
[1] Kantar Hlth, Hlth Outcomes Practice, 1 Independence Way,Suite 220, Princeton, NJ 08540 USA
[2] Eisai Inc, Hlth Econ & Outcomes Res, Woodcliff Lake, NJ USA
关键词
Body mass index; type; 2; diabetes; weight loss medication; weight loss satisfaction;
D O I
10.1111/cob.12140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Satisfaction with weight loss (WL) methods has been correlated with the effectiveness, long-term compliance and commitment to weight management. This study explored treatment satisfaction associated with different WL methods among patients with obesity. Cross-sectional data were analysed from the 2012 US National Health and Wellness Survey. Respondents with obesity were categorized as having a WL procedure (e.g., gastric bypass and gastric banding) or using a prescription medication for WL (Sur/Rx), vs. using self-modification WL techniques (e.g., diet, exercise and WL supplements). Overall satisfaction with current WL methods was assessed among the obese and the overweight/obese with type 2 diabetes mellitus (T2DM). Of the 22 927 respondents with obesity, 58.4% took no current action to lose weight, 2.3% were identified as Sur/Rx and 39.3% were identified as self-modification. The Sur/Rx group reported being very/extremely satisfied more frequently than the self-modification group (39.3% vs. 20.2%, P < 0.001). Similarly, respondents with T2DM that were overweight/obese reported higher satisfaction in the Sur/Rx vs. the self-modification group (46.6% vs. 22.7%, P < 0.001). Satisfaction with WL methods was greater for the Sur/Rx vs. the self-modification group. Data suggest the importance of including bariatric surgery and pharmacotherapy as an integral part in comprehensive WL management.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 50 条
  • [41] Health risks associated with weight loss and obesity treatment programs
    Berg, FM
    JOURNAL OF SOCIAL ISSUES, 1999, 55 (02) : 277 - 297
  • [42] Safety of drug therapies used for weight loss and treatment of obesity
    Ioannides-Demos, LL
    Proietto, J
    Tonkin, AM
    McNeil, JJ
    DRUG SAFETY, 2006, 29 (04) : 277 - 302
  • [43] Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity
    Rogovik, Alexander L.
    Chanoine, Jean-Pierre
    Goldman, Ran D.
    DRUGS, 2010, 70 (03) : 335 - 346
  • [44] Self-efficacy, attendance, and weight loss in obesity treatment
    Fontaine, KR
    Cheskin, LJ
    ADDICTIVE BEHAVIORS, 1997, 22 (04) : 567 - 570
  • [45] Behavioral Weight Loss: A Promising Treatment for Obesity in Adults with HIV
    Panza, Emily
    Wing, Edward J.
    Wing, Rena
    AIDS AND BEHAVIOR, 2020, 24 (04) : 1085 - 1091
  • [46] Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy
    Kushner, Robert F.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 61 (02) : 246 - 252
  • [47] Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity
    Alexander L. Rogovik
    Jean-Pierre Chanoine
    Ran D. Goldman
    Drugs, 2010, 70 : 335 - 346
  • [48] Personality, attrition and weight loss in treatment seeking women with obesity
    Dalle Grave, R.
    Calugi, S.
    Compare, A.
    El Ghoch, M.
    Petroni, M. L.
    Colombari, S.
    Minniti, A.
    Marchesini, G.
    CLINICAL OBESITY, 2015, 5 (05) : 266 - 272
  • [49] Weight-Loss Diets for the Prevention and Treatment of Obesity.
    Katan, Martijn B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (09): : 923 - 925
  • [50] Weight Loss Using an mHealth App Among Individuals With Obesity in Different Economic Regions of China: Cohort Study
    Huang, Xinru
    Shi, Yefei
    Yao, Hongyun
    Li, Mingjie
    Lei, Zhijun
    Shi, Jiayun
    Li, Bo
    Zhang, Weiwei
    Jian, Weixia
    JMIR MHEALTH AND UHEALTH, 2024, 12